Details of the Drug Formulaction

General Information of Drug Formulation (ID: F23895)

Formulation Name
Siponimod 0.25mg tablet
Company
Novartis Pharmaceuticals Corporation
Pharmaceutical Drug(s) in Formulation
Drug Name Drug ID Indication ICD 11 Status
Siponimod DM2R86O Multiple sclerosis 8A40 Approved
Pharmaceutical Excipient(s) in Formulation
Excipient Name Excipient ID PubChem CID Functional Classification
Cellulose microcrystalline E00698 Not Available Adsorbent; Suspending agent; Diluent
Crospovidone E00626 Not Available Disintegrant
Ferric oxide black E00522 16211978 Colorant
Glyceryl behenate E00481 5362585 Binding agent; Coating agent; Flavoring agent; Modified-release agent; Viscosity-controlling agent; lubricant
Haematite red E00236 14833 Colorant
Hydrophobic colloidal silica E00285 24261 Anticaking agent; Emulsion stabilizing agent; Glidant; Suspending agent; Viscosity-controlling agent
Lactose monohydrate E00393 104938 Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Polyvinyl alcohol E00666 Not Available Coating agent; Emulsion stabilizing agent; Film/Membrane-forming agent
Soybean lecithin E00637 Not Available Other agent
Talc E00520 16211421 Anticaking agent; Diluent; Glidant; lubricant
Titanium dioxide E00322 26042 Coating agent; Colorant; Opacifying agent
Xanthan gum E00694 Not Available Bioadhesive material; Emulsifying agent; Gelling agent; Modified-release agent; Suspending agent; Viscosity-controlling agent